Biodesix Inc
BDSXNasdaqCIK 1439725HealthcareFiscal year ends Dec 31
Reports and events: 114 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0520:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335036 |
| 2026-08-0520:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335010 |
| 2026-05-2020:18 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-232631 |
| 2026-05-0420:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-203960 |
| 2026-05-0420:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-203936 |
| 2026-04-0920:14 ET | DEF 14A | Proxy statementPeriod 2026-05-19 | 0001193125-26-149633 |
| 2026-02-2621:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076547 |
| 2026-02-2621:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076521 |
| 2026-01-2719:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-26-000363 |
| 2026-01-1217:04 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-010114 |
| 2025-11-0321:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-262532 |
| 2025-11-0321:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-262508 |
| 2025-10-0120:05 ET | 8-K | 8.01 Other events | 0001193125-25-226749 |
| 2025-09-2313:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-003393 |
| 2025-09-1521:01 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-203746 |
| 2025-09-1112:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-200766 |
| 2025-09-0320:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-003282 |
| 2025-08-0720:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105026 |
| 2025-08-0720:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439725-25-000003 |
| 2025-05-2120:43 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-124047 |
| 2025-05-2020:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000905148-25-001862 |
| 2025-05-1320:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070339 |
| 2025-05-1320:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070292 |
| 2025-04-2820:06 ET | DEF 14A | Proxy statementPeriod 2025-05-20 | 0001193125-25-100458 |
| 2025-04-1720:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-084319 |
| 2025-03-2820:01 ET | 8-K | 3.01 Delisting notice | 0000950170-25-046748 |
| 2025-03-0321:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-030835 |
| 2025-03-0321:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-030814 |
| 2025-01-1011:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-003717 |
| 2024-11-0110:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-119792 |
| 2024-11-0110:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-119791 |
| 2024-08-1501:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-200857 |
| 2024-08-0720:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092773 |
| 2024-08-0720:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092722 |
| 2024-05-2420:11 ET | S-1/A | Registration statement, amended | 0001193125-24-147047 |
| 2024-05-2323:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-027326 |
| 2024-05-2323:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-027325 |
| 2024-05-2320:10 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-145965 |
| 2024-05-0820:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055651 |
| 2024-05-0820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055608 |
| 2024-04-2620:13 ET | DEF 14A | Proxy statementPeriod 2024-05-21 | 0001193125-24-118069 |
| 2024-04-2320:18 ET | S-1 | Registration statement | 0001193125-24-107051 |
| 2024-04-0900:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-018955 |
| 2024-04-0900:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-018954 |
| 2024-04-0923:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-018946 |
| 2024-04-0923:40 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-018943 |
| 2024-04-0920:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-090787 |
| 2024-03-0111:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023513 |
| 2024-03-0111:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023509 |
| 2023-12-2014:19 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-071761 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.